Home » Investor Information
Investor Information
Century Pharmaceuticals Ltd welcomes the future with open arms. Looking into the past, we have built a strong present to face a challenging future. The company has a vision to enter into new markets, launch innovative products, and build a brand that will carry itself across the world.
We welcome NGOs, Government financial institutions, Venture Capitalists, PE investors, Pharmaceutical and Biotechnology companies to invest with us in the development of a novel recombinant protein for the treatment and cure of Asthma and Allergies for the first time in the world. Other indications are Mastocytosis and Basophilic Leukemia. Once we are able to successfully develop this product, we will provide a new direction to targeted therapeutics for other chronic diseases like Leukemia and find cures for them !
COLLABORATIONS AND PARTNERSHIPS
- MOU signed for collaborative Research project Sumandeep vidya peeth, Wagodia Gujarat for development of Recombinant fusion proteins for the treatment of Asthma and allergy.
- MOU signed and collaborated with Parul Institute of Pharmacy Wagodia Gujarat for developing Therapeutic application of Defensin under Industry academic partnerships.
- MOU signed and collaborated with ICAR Institute of Fisheries Research Mumbai for the developing Therapeutic application of Pholorotanin under Industry academic partnerships.
LICENSE AND TECHNOLOGY TRANSFER
Licensed to develop and market worldwide for the project on Recombinant proteins for the treatment of Asthma and Allergy by Israeli Biotech Company Target-In.
Looking at investment opportunities? Please click here.